The perilous path of biotech drugs

The perilous path of biotech drugs
“The idea for a revolutionary new drug to treat allergies and asthma came to scientist Tse Wen Chang in a dream …
It would take 16 years and cost the Changs and their partners, Genentech and Novartis, hundreds of millions of dollars to develop the drug and win government approval. And it still may fall short of expectations.”

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog